Adelaide Research & Scholarship: Browsing DSpace

Browsing "University Library" by Author Eadie, L.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:

Showing results 4 to 10 of 10 < previous

Preview	Issue Date	Title	Author(s)
	2008	Dasatinib cellular uptake and efflux in chronic myeloid leukemia cells: therapeutic implications	Hiwase, D.; Saunders, V.; Hewett, D.; Frede, A.; Zrim, S.; Dang, P.; Eadie, L.; To, L.; Vaz de Melo, J.; Kumar, S.; Hughes, T.; White, D.
	2013	Degree of kinase inhibition achieved in vitro by imatinib and nilotinib is decreased by high levels of ABCB1 but not ABCG2	Eadie, L.; Saunders, V.; Hughes, T.; White, D.
	2019	High risk genomic alterations identified at the time of diagnosis are strongly associated with MRD and subsequent poor outcomes in AYA ALL patients treated on a pediatric inspired chemotherapy regimen	Yeung, D.; Greenwood, M.; Rehn, J.; Heatley, S.; McClure, B.; Eadie, L.; Breen, J.; Schutz, C.; Trahair, T.; Wei, A.; Dalla-Pozza, L.; Sutton, R.; Bradstock, K.; Osborn, M.; White, D.; American Society of Hematology Annual Meeting (ASH) (7 Dec 2019 - 10 Dec 2019 : Orlando, CA)
	2014	Interaction of the efflux transporters ABCB1 and ABCG2 with imatinib, nilotinib, and dasatinib	Eadie, L.; Hughes, T.; White, D.
	2005	Microsatellite (SSR) diversity among Australian Rhynchosporium secalis isolates	Keiper, F.; Scott, L.; Eadie, L.; Hayden, M.; Wallwork, H.; Australian Barley Technical Symposium (12th : 2005 : Hobart, Tasmania)
	2010	Nilotinib does not significantly reduce imatinib OCT-1 activity in either cell lines or primary CML cells	Eadie, L.; Hughes, T.; White, D.
	2013	Proton pump inhibitors significantly increase the intracellular concentration of nilotinib, but not imatinib in target CML cells	White, D.; Eadie, L.; Saunders, V.; Hiwase, D.; Hughes, T.

Showing results 4 to 10 of 10 < previous